Clive S. Zent

9.0k total citations
192 papers, 5.3k citations indexed

About

Clive S. Zent is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Clive S. Zent has authored 192 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Genetics, 115 papers in Pathology and Forensic Medicine and 89 papers in Immunology. Recurrent topics in Clive S. Zent's work include Chronic Lymphocytic Leukemia Research (166 papers), Lymphoma Diagnosis and Treatment (109 papers) and Immunodeficiency and Autoimmune Disorders (65 papers). Clive S. Zent is often cited by papers focused on Chronic Lymphocytic Leukemia Research (166 papers), Lymphoma Diagnosis and Treatment (109 papers) and Immunodeficiency and Autoimmune Disorders (65 papers). Clive S. Zent collaborates with scholars based in United States, Netherlands and Belarus. Clive S. Zent's co-authors include Neil E. Kay, Tait D. Shanafelt, Timothy G. Call, Diane F. Jelinek, Deborah A. Bowen, Susan L. Slager, Betsy LaPlant, Susan M. Schwager, Renee C. Tschumper and Curtis A. Hanson and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Clive S. Zent

185 papers receiving 5.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Clive S. Zent 3.5k 2.9k 2.2k 966 881 192 5.3k
Timothy G. Call 4.0k 1.1× 3.4k 1.1× 2.2k 1.0× 837 0.9× 1.1k 1.2× 221 5.8k
Anders Österborg 2.7k 0.8× 2.5k 0.8× 3.2k 1.4× 1.5k 1.5× 2.2k 2.5× 204 7.5k
Fritz Offner 2.0k 0.6× 2.7k 0.9× 1.1k 0.5× 1.3k 1.3× 2.3k 2.6× 236 6.1k
W. Hunstein 1.5k 0.4× 1.3k 0.5× 1.4k 0.6× 1.1k 1.1× 1.9k 2.1× 194 5.2k
Philip A. Thompson 2.0k 0.6× 1.6k 0.5× 815 0.4× 631 0.7× 838 1.0× 169 3.4k
Joseph M. Tuscano 777 0.2× 1.4k 0.5× 932 0.4× 1.1k 1.1× 1.3k 1.5× 150 4.3k
Gunnar Juliusson 4.4k 1.3× 2.8k 0.9× 2.3k 1.0× 2.9k 3.0× 2.4k 2.7× 189 9.0k
Lothar Bergmann 662 0.2× 798 0.3× 1.0k 0.5× 2.1k 2.1× 1.4k 1.5× 182 4.8k
Chaim Shustik 1.0k 0.3× 1.1k 0.4× 455 0.2× 2.0k 2.0× 1.9k 2.2× 74 4.5k
Jordi Esteve 1.8k 0.5× 1.2k 0.4× 759 0.3× 2.6k 2.7× 1.8k 2.0× 262 7.6k

Countries citing papers authored by Clive S. Zent

Since Specialization
Citations

This map shows the geographic impact of Clive S. Zent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clive S. Zent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clive S. Zent more than expected).

Fields of papers citing papers by Clive S. Zent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clive S. Zent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clive S. Zent. The network helps show where Clive S. Zent may publish in the future.

Co-authorship network of co-authors of Clive S. Zent

This figure shows the co-authorship network connecting the top 25 collaborators of Clive S. Zent. A scholar is included among the top collaborators of Clive S. Zent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clive S. Zent. Clive S. Zent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McNitt, Scott, et al.. (2023). Risk of New-Onset Atrial Fibrillation Associated With Targeted Treatment of Lymphoma. JACC Advances. 2(8). 100602–100602. 1 indexed citations
2.
Zent, Clive S., Andrea Baran, Patrick M. Reagan, et al.. (2023). Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia. Blood Advances. 7(11). 2496–2503. 6 indexed citations
3.
Strawderman, Myla, Patrick M. Reagan, Paul M. Barr, et al.. (2023). Healthcare Utilization Disparities of Adolescent and Young Adults Compared to the Older Lymphoma Population. Clinical Lymphoma Myeloma & Leukemia. 23(9). e260–e267. 1 indexed citations
4.
Hill, Brian T., Shuo Ma, Clive S. Zent, et al.. (2023). Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia. Blood Advances. 8(2). 378–387. 4 indexed citations
5.
Sherazi, Saadia, Scott McNitt, Carla Casulo, et al.. (2023). Arrhythmogenic Cardiotoxicity Associated With Contemporary Treatments of Lymphoproliferative Disorders. Journal of the American Heart Association. 12(6). e025786–e025786. 1 indexed citations
6.
Rivera‐Escalera, Fátima, et al.. (2023). Antibody‐mediated phagocytosis in cancer immunotherapy. Immunological Reviews. 319(1). 128–141. 22 indexed citations
7.
Baran, Andrea, et al.. (2021). Targeted therapy for treatment of patients with classical hairy cell leukemia. Leukemia Research. 102. 106522–106522. 7 indexed citations
8.
Williams, AnnaLynn M., Andrea Baran, Patrick M. Reagan, et al.. (2020). Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma. Leukemia & lymphoma. 62(3). 598–605. 1 indexed citations
9.
Chu, Charles C., Jonathan J. Pinney, Fátima Rivera‐Escalera, et al.. (2020). High-resolution quantification of discrete phagocytic events by live cell time-lapse high-content microscopy imaging. Journal of Cell Science. 133(5). 9 indexed citations
10.
Pinney, Jonathan J., Fátima Rivera‐Escalera, Charles C. Chu, et al.. (2020). Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance. Blood. 136(18). 2065–2079. 25 indexed citations
11.
Williams, AnnaLynn M., Andrea Baran, Carla Casulo, et al.. (2018). Ibrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center Experience. Clinical Lymphoma Myeloma & Leukemia. 19(1). 41–47. 18 indexed citations
12.
VanDerMeid, Karl R., Michael R. Elliott, Andrea Baran, et al.. (2018). Cellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies. Cancer Immunology Research. 6(10). 1150–1160. 56 indexed citations
13.
Archibald, William J., AnnaLynn M. Williams, Andrea Baran, et al.. (2018). Management of melanoma in patients with chronic lymphocytic leukemia. Leukemia Research. 71. 43–46. 18 indexed citations
14.
Williams, AnnaLynn M., Andrea Baran, Carla Casulo, et al.. (2017). Increased Risk of Toxicity with Novel PI3K Delta Inhibitor Combinations Compared with Standard Use in Non-Hodgkin Lymphoma Patients. Blood. 130. 4050–4050. 1 indexed citations
15.
Cook, Erika M., Margaret A. Lindorfer, Simone C. Oostindie, et al.. (2016). Antibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions. The Journal of Immunology. 197(5). 1762–1775. 48 indexed citations
16.
Bowen, Deborah A., Kari G. Rabe, Susan M. Schwager, et al.. (2014). Infectious lymphadenitis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: a rare, but important, complication. Leukemia & lymphoma. 56(2). 311–314. 13 indexed citations
17.
Mráz, Marek, Clive S. Zent, Diane F. Jelinek, et al.. (2011). Bone marrow stromal cells protect lymphoma B‐cells from rituximab‐induced apoptosis and targeting integrin α‐4‐β‐1 (VLA‐4) with natalizumab can overcome this resistance. British Journal of Haematology. 155(1). 53–64. 92 indexed citations
18.
Shanafelt, Tait D., Matthew T. Drake, Matthew J. Maurer, et al.. (2010). Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood. 117(5). 1492–1498. 104 indexed citations
19.
Shanafelt, Tait D., Timothy G. Call, Grzegorz S. Nowakowski, et al.. (2005). Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies. Leukemia Research. 30(6). 707–712. 71 indexed citations
20.
Zent, Clive S. & Harvey M. Golomb. (1997). Treatment Options for Hairy Cell Leukemia. PubMed. 18(5 Suppl 7). 132–138. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy G. Call Breakdown of academic impact, for papers by Anders Österborg Breakdown of academic impact, for papers by Fritz Offner Breakdown of academic impact, for papers by W. Hunstein Breakdown of academic impact, for papers by Philip A. Thompson Breakdown of academic impact, for papers by Joseph M. Tuscano Breakdown of academic impact, for papers by Gunnar Juliusson Breakdown of academic impact, for papers by Lothar Bergmann Breakdown of academic impact, for papers by Chaim Shustik Breakdown of academic impact, for papers by Jordi Esteve
Rankless by CCL
2026